CDKN2A (original) (raw)
CDKN2A, also known as cyclin-dependent kinase inhibitor 2A, is a gene which in humans is located at chromosome 9, band p21.3. It is ubiquitously expressed in many tissues and cell types. The gene codes for two proteins, including the INK4 family member p16 (or p16INK4a) and p14arf. Both act as tumor suppressors by regulating the cell cycle. p16 inhibits cyclin dependent kinases 4 and 6 (CDK4 and CDK6) and thereby activates the retinoblastoma (Rb) family of proteins, which block traversal from G1 to S-phase. p14ARF (known as p19ARF in the mouse) activates the p53 tumor suppressor. Somatic mutations of CDKN2A are common in the majority of human cancers, with estimates that CDKN2A is the second most commonly inactivated gene in cancer after p53. Germline mutations of CDKN2A are associated wit
| Property | Value |
|---|---|
| dbo:abstract | CDKN2A, also known as cyclin-dependent kinase inhibitor 2A, is a gene which in humans is located at chromosome 9, band p21.3. It is ubiquitously expressed in many tissues and cell types. The gene codes for two proteins, including the INK4 family member p16 (or p16INK4a) and p14arf. Both act as tumor suppressors by regulating the cell cycle. p16 inhibits cyclin dependent kinases 4 and 6 (CDK4 and CDK6) and thereby activates the retinoblastoma (Rb) family of proteins, which block traversal from G1 to S-phase. p14ARF (known as p19ARF in the mouse) activates the p53 tumor suppressor. Somatic mutations of CDKN2A are common in the majority of human cancers, with estimates that CDKN2A is the second most commonly inactivated gene in cancer after p53. Germline mutations of CDKN2A are associated with familial melanoma, glioblastoma and pancreatic cancer. The CDKN2A gene also contains one of 27 SNPs associated with increased risk of coronary artery disease. (en) CDKN2A (англ. Cyclin dependent kinase inhibitor 2A) – білок, який кодується однойменним геном, розташованим у людей на короткому плечі 9-ї хромосоми. Довжина поліпептидного ланцюга білка становить 156 амінокислот, а молекулярна маса — 16 533. Послідовність амінокислот A: АланінC: ЦистеїнD: Аспарагінова кислотаE: Глутамінова кислотаF: ФенілаланінG: ГліцинH: ГістидинI: ІзолейцинL: ЛейцинM: МетіонінN: АспарагінP: ПролінQ: ГлутамінR: АргінінS: СеринT: ТреонінV: ВалінW: Триптофан Y: Тирозин Кодований геном білок за функцією належить до фосфопротеїнів. Задіяний у таких біологічних процесах, як клітинний цикл, ацетилювання, альтернативний сплайсинг. Локалізований у цитоплазмі, ядрі. (uk) |
| dbo:wikiPageID | 14842113 (xsd:integer) |
| dbo:wikiPageLength | 25873 (xsd:nonNegativeInteger) |
| dbo:wikiPageRevisionID | 1110507964 (xsd:integer) |
| dbo:wikiPageWikiLink | dbr:Ankyrin_repeats dbr:SNPs dbr:Cyclin-dependent_kinase_4 dbr:Cyclin-dependent_kinase_6 dbr:Unified_atomic_mass_unit dbr:E2F dbr:P14arf dbr:P53 dbr:Melanoma dbr:Retinoblastoma_protein dbr:Gene dbr:Glioblastoma dbr:Mitochondrion dbr:Coronary_artery_disease dbr:Apoptosis dbr:Pancreatic_cancer dbr:Tumor_suppressor_gene dbr:G1_phase dbr:G2_phase dbr:P16 dbr:Alternative_splicing dbr:Cell_cycle dbr:Cellular_senescence dbr:Reading_frame dbr:Protein dbr:Histiocytic_sarcoma dbr:Hydrophobic_effect dbc:Genes dbr:Tertiary_structures dbr:Chromosome_9_(human) dbr:Cyclin-dependent_kinase_inhibitor_proteins dbr:Reactive_oxygen_species dbr:S_phase dbr:Solvent dbr:Exon dbr:INK4 dbr:Immunosuppression dbr:N-terminus dbr:MDM2 dbr:P14ARF dbr:Amino_acid_sequence dbr:Helix-turn-helix_motif dbr:Positively_charged dbr:CDK4 dbr:Isoforms dbr:Negatively_charged dbr:Protein_kinase_C_delta |
| dbp:wikiPageUsesTemplate | dbt:Infobox_gene dbt:Reflist dbt:Short_description dbt:UCSC_gene_info |
| dcterms:subject | dbc:Genes |
| gold:hypernym | dbr:Gene |
| rdf:type | owl:Thing dbo:Biomolecule dbo:Gene wikidata:Q206229 wikidata:Q7187 dbo:HumanGene dbo:Protein |
| rdfs:comment | CDKN2A, also known as cyclin-dependent kinase inhibitor 2A, is a gene which in humans is located at chromosome 9, band p21.3. It is ubiquitously expressed in many tissues and cell types. The gene codes for two proteins, including the INK4 family member p16 (or p16INK4a) and p14arf. Both act as tumor suppressors by regulating the cell cycle. p16 inhibits cyclin dependent kinases 4 and 6 (CDK4 and CDK6) and thereby activates the retinoblastoma (Rb) family of proteins, which block traversal from G1 to S-phase. p14ARF (known as p19ARF in the mouse) activates the p53 tumor suppressor. Somatic mutations of CDKN2A are common in the majority of human cancers, with estimates that CDKN2A is the second most commonly inactivated gene in cancer after p53. Germline mutations of CDKN2A are associated wit (en) CDKN2A (англ. Cyclin dependent kinase inhibitor 2A) – білок, який кодується однойменним геном, розташованим у людей на короткому плечі 9-ї хромосоми. Довжина поліпептидного ланцюга білка становить 156 амінокислот, а молекулярна маса — 16 533. Послідовність амінокислот A: АланінC: ЦистеїнD: Аспарагінова кислотаE: Глутамінова кислотаF: ФенілаланінG: ГліцинH: ГістидинI: ІзолейцинL: ЛейцинM: МетіонінN: АспарагінP: ПролінQ: ГлутамінR: АргінінS: СеринT: ТреонінV: ВалінW: Триптофан Y: Тирозин (uk) |
| rdfs:label | CDKN2A (en) CDKN2A (uk) |
| owl:sameAs | freebase:CDKN2A yago-res:CDKN2A wikidata:CDKN2A dbpedia-cy:CDKN2A dbpedia-da:CDKN2A dbpedia-uk:CDKN2A https://global.dbpedia.org/id/4eQtP |
| prov:wasDerivedFrom | wikipedia-en:CDKN2A?oldid=1110507964&ns=0 |
| foaf:isPrimaryTopicOf | wikipedia-en:CDKN2A |
| is dbo:wikiPageRedirects of | dbr:Cyclin-dependent_kinase_inhibitor_2A dbr:Cyclin_dependent_kinase_inhibitor_2A |
| is dbo:wikiPageWikiLink of | dbr:Epitranscriptome dbr:Monomorphic_epitheliotropic_intestinal_T_cell_lymphoma dbr:Primary_cutaneous_diffuse_large_B-cell_lymphoma,_leg_type dbr:Primary_testicular_diffuse_large_B-cell_lymphoma dbr:Antisense_RNA dbr:Dysplastic_nevus_syndrome dbr:List_of_human_protein-coding_genes_1 dbr:Melanoma dbr:STK35L1 dbr:Enteropathy-associated_T-cell_lymphoma dbr:Myocardial_infarction dbr:Pancreatic_cancer dbr:MiR-125 dbr:Adenocarcinoma_of_the_lung dbr:Adenomatoid_tumor dbr:Jun_dimerization_protein dbr:Li–Fraumeni_syndrome dbr:P16 dbr:Acute_lymphoblastic_leukemia dbr:Adrenocortical_carcinoma dbr:Follicular_lymphoma dbr:Richter's_transformation dbr:HPV-positive_oropharyngeal_cancer dbr:Chordoma dbr:T-Cell_Acute_Lymphoblastic_Leukemia dbr:CCDC180 dbr:CDKN2D dbr:Cancer_epigenetics dbr:Vero_cell dbr:In_situ_lymphoid_neoplasia dbr:Myxofibrosarcoma dbr:Squamous-cell_carcinoma_of_the_lung dbr:Porocarcinoma dbr:Sex-linked_barring dbr:ZBTB48 dbr:Pharmacoepigenetics dbr:Papillary_renal_cell_carcinoma dbr:Cyclin-dependent_kinase_inhibitor_2A dbr:Cyclin_dependent_kinase_inhibitor_2A |
| is foaf:primaryTopic of | wikipedia-en:CDKN2A |